Antti Poso

Antti Poso, Tuomo Laitinen, Ossi Korhonen, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Comparative and pharmacophore model for deacetylase SIRT1

Antti Poso, Tuomo Laitinen, Jukka Leppänen, 2006, J. Comput. Aided Mol. Des..

Assessment of mutation probabilities of KRAS G12 missense mutants and their long-timescale dynamics by atomistic molecular simulations and Markov state modeling

Antti Poso, Tuomo Laitinen, Ilpo Vattulainen, 2018, PLoS Comput. Biol..

The application of machine learning techniques to innovative antibacterial discovery and development

Antti Poso, Vinícius Gonçalves Maltarollo, P. R. Oliveira, 2020, Expert opinion on drug discovery.

Monitoring the wetting phase of fluidized bed granulation process using multi-way methods: The separation of successful from unsuccessful batches

Antti Poso, Jarkko Ketolainen, Satu-Pia Reinikainen, 2009 .

Integrative and Personalized QSAR Analysis in Cancer by Kernelized Bayesian Matrix Factorization

Krister Wennerberg, Samuel Kaski, Elisabeth Georgii, 2014, J. Chem. Inf. Model..

BRUTUS: Optimization of a grid-based similarity function for rigid-body molecular superposition. II. Description and characterization

Jussi Parkkinen, Antti Poso, Toni Rönkkö, 2006, J. Comput. Aided Mol. Des..

Comparing the Quality and Predictiveness between 3D QSAR Models Obtained from Manual and Automated Alignment

Tommi H. Nyrönen, Antti Poso, Toni Rönkkö, 2004, J. Chem. Inf. Model..

Uncertainty in dissolution test of drug release

Antti Poso, Jarkko Ketolainen, Satu-Pia Reinikainen, 2009 .

The Effect of Ligand-Based Tautomer and Protomer Prediction on Structure-Based Virtual Screening

Antti Poso, Tuomo Kalliokoski, Maija Lahtela-Kakkonen, 2009, J. Chem. Inf. Model..

A comparative molecular field analysis of cytochrome P450 2A5 and 2A6 inhibitors

Antti Poso, Risto Juvonen, Jukka Gynther, 2001, J. Comput. Aided Mol. Des..

Structural Characterization of LsrK as a Quorum Sensing Target and a Comparison between X-ray and Homology Models

Antti Poso, Tuomo Laitinen, Prasanthi Medarametla, 2021, J. Chem. Inf. Model..

The feasibility of using acoustic emissions for monitoring of fluidized bed granulation

Antti Poso, Jarkko Ketolainen, Reijo Lappalainen, 2009 .

Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.

Antti Poso, Hannu Raunio, Carsten Wittekindt, 2005, Journal of medicinal chemistry.

Virtual screening of novel CB2 ligands using a comparative model of the human cannabinoid CB2 receptor.

Antti Poso, Tomi Järvinen, Maija Lahtela-Kakkonen, 2005, Journal of medicinal chemistry.

Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system.

Antti Poso, Tomi Järvinen, A. Poso, 2006, Journal of medicinal chemistry.

Insights into ligand-elicited activation of human constitutive androstane receptor based on novel agonists and three-dimensional quantitative structure-activity relationship.

Johanna Jyrkkärinne, Jenni Küblbeck, Paavo Honkakoski, 2008, Journal of medicinal chemistry.

Chemical space of orally active compounds

Antti Poso, Jarkko Ketolainen, Ossi Korhonen, 2006 .

Comparative molecular field analysis and molecular dynamics studies of α/β hydrolase domain containing 6 (ABHD6) inhibitors

Antti Poso, Tuomo Laitinen, Agnieszka A. Kaczor, 2015, Journal of Molecular Modeling.

3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.

Antti Poso, Tomi Järvinen, Maija Lahtela-Kakkonen, 2006, Journal of medicinal chemistry.

Development of a 3D model for the human cannabinoid CB1 receptor.

Antti Poso, Tomi Järvinen, Maija Lahtela-Kakkonen, 2004, Journal of medicinal chemistry.

Identification of novel SIRT3 inhibitor scaffolds by virtual screening.

Antti Poso, Tuomo Laitinen, Maija Lahtela-Kakkonen, 2013, Bioorganic & medicinal chemistry letters.

Comparative Molecular Field Analysis of Compounds with CYP2A5 Binding Affinity

Antti Poso, Risto O. Juvonen, Jukka Gynther, 1995 .

BRUTUS: optimization of a grid-based similarity function for rigid-body molecular superposition. 1. Alignment and virtual screening applications.

Antti Poso, Toni Rönkkö, Anu J. Tervo, 2005, Journal of medicinal chemistry.

Quantitative insights for the design of substrate-based SIRT1 inhibitors.

Antti Poso, Olli Nyrhilä, Piia Kokkonen, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

The Effect of Ligand-Based Tautomer and Protomer Prediction on Structure-Based Virtual Screening.

Antti Poso, Tuomo Kalliokoski, Maija Lahtela-Kakkonen, 2010 .

An in silico approach to discovering novel inhibitors of human sirtuin type 2.

Antti Poso, Jukka Leppänen, Tomi Järvinen, 2004, Journal of medicinal chemistry.

Estimation of granule size distribution for batch fluidized bed granulation process using acoustic emission and N‐way PLS

Antti Poso, Jarkko Ketolainen, Satu-Pia Reinikainen, 2010 .

Discovering inhibitors of human sirtuin type 2: novel structural scaffolds.

Antti Poso, Jukka Leppänen, Anu J. Tervo, 2006, Journal of medicinal chemistry.

Identification of WIN55212‐3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor

Antti Poso, Tomi Järvinen, A. Poso, 2005, British journal of pharmacology.

Correlation between calculated molecular descriptors of excipient amino acids and experimentally observed thermal stability of lysozyme.

Antti Poso, Jukka Rantanen, Holger Grohganz, 2017, International journal of pharmaceutics.

Screening of Various Hormone‐Sensitive Lipase Inhibitors as Endocannabinoid‐Hydrolyzing Enzyme Inhibitors

Henri Xhaard, Antti Poso, Jukka Leppänen, 2009, ChemMedChem.

Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors.

Antti Poso, Jukka Leppänen, Carsten Wittekindt, 2008, Journal of medicinal chemistry.

Discovery of novel cannabinoid receptor ligands by a virtual screening approach: further development of 2,4,6-trisubstituted 1,3,5-triazines as CB2 agonists.

Antti Poso, Tuomo Laitinen, Tuomo Kalliokoski, 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Discovery of substituted sulfonamides and thiazolidin-4-one derivatives as agonists of human constitutive androstane receptor.

Johanna Jyrkkärinne, Jenni Küblbeck, Paavo Honkakoski, 2008, Biochemical pharmacology.

Virtual screening approach of sirtuin inhibitors results in two new scaffolds.

Antti Poso, Piia Kokkonen, Maija Lahtela-Kakkonen, 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Multi‐Component Protein – Protein Docking Based Protocol with External Scoring for Modeling Dimers of G Protein‐Coupled Receptors

Stefan Dove, Antti Poso, Pau Carrió, 2015, Molecular informatics.

Predicting Plasticization Efficiency from Three-Dimensional Molecular Structure of a Polymer Plasticizer

Antti Poso, A. Poso, R. Sutinen, 2001, Pharmaceutical Research.

Modelling of molecular mutagenicity with comparative molecular field analysis (CoMFA). Structural and electronic properties of MX compounds related to TA 100 mutagenicity

Antti Poso, Kari Tuppurainen, Jukka Gynther, 1994 .

Structure‐Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics

Peter Kolb, Antti Poso, Agnieszka A Kaczor, 2016, ChemMedChem.

Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2.

Antti Poso, Jukka Leppänen, Tero Huhtiniemi, 2011, Journal of medicinal chemistry.

Binding of some dioxins and dibenzofurans to the Ah receptor. A QSAR model based on comparative molecular field analysis (CoMFA)

Antti Poso, Juhani Ruuskanen, Kari Tuppurainen, 1993 .

Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.

Antti Poso, Hannu Raunio, Carsten Wittekindt, 2005, Journal of medicinal chemistry.